Medical reporter Cathryn Delude from the LA Times (“New hope for celiac disease sufferers?”, December 21st 2009) talks with Nexpep CEO Dr Robert Anderson about Nexvax2, the coeliac vaccine currently in a clinical trial in Australia.
[Read the rest of this article...]